"Thicker hair" is one of the most common promises in the category, and one of the least often measured. Thickness is the diameter of a single hair; density is how many hairs there are. Most trials count hairs. Almost none measure how wide they are.
Searching PubMed on 2026-09-10 for peptide[tiab] AND (hair shaft diameter[tiab] OR hair diameter[tiab] OR hair thickness[tiab]) returns six records — against 379 for hair shaft diameter as a subject on its own. Reading the six is the fastest way to see where this claim stands, because five of them are not the kind of product the claim usually appears on.
The six
| Study | Format | Population | Hair endpoint |
|---|---|---|---|
| GPIGS pentapeptide, J Cosmet Dermatol 2016 | Topical lotion | 22 Japanese men with androgenetic alopecia | Proportion of hairs ≥60 μm |
| Low-molecular-weight collagen peptide, J Med Food 2026 | Oral, 1,000 mg/day | 114 women, 20–50, cellulite + self-reported thinning | Hair diameter at 24 weeks |
| Collagen peptide GT, Int J Stem Cells 2026 | Oral, 3 g/day | Korean adults 19–60, damaged hair, no alopecia | Hair gloss |
| Fish collagen peptide GPVGPS, J Med Food 2025 | Oral / cells | Human dermal papilla cells and mice | Regrowth in animals |
| Collagen supplementation review, Nutrients 2026 | Narrative review | — | Summarises the above |
| Copper tripeptide scalp regimen, Cureus 2024 | Topical scrub + treatment | Open-label assessment | Safety, efficacy, tolerability |
Five of the six are collagen peptides taken by mouth. The topical cosmetic peptides that dominate the "thickening" shelf — the ones sold in serums and sprays — contribute exactly one trial to this list.
The one topical trial, and what its endpoint means
The GPIGS study is described in detail on peptides for hair growth in men as the best-designed trial in the category. Here the interesting part is not the design but the ruler.
The authors did not report an average hair diameter. They set two thresholds — 60 μm and above is a thick hair, below 40 μm is a vellus hair — and reported the change in the proportion of hairs falling in each band. In the peptide group the thick-hair proportion rose significantly more than in placebo (P = 0.006) and the vellus proportion fell (P = 0.029). Blinded photographic grading also favoured the peptide (P = 0.020).
A proportion-above-threshold endpoint behaves differently from a mean. It can move a long way because a large number of hairs sitting just under 60 μm crossed the line by a small amount, which is a genuine change in the direction of terminal hair but not the dramatic thickening the phrasing suggests. It can also stay flat while every hair thickens substantially, if none of them started near the boundary. Neither behaviour is a flaw — thresholds are how trichology distinguishes terminal from miniaturised hair — but it does mean "increased the proportion of thick hair" and "made hair thicker" are not interchangeable sentences.
Why calibre is the endpoint that fits the condition
For androgenetic alopecia in particular, diameter is arguably the more sensitive measure. The characteristic early change is miniaturisation: the same follicles, still present and still cycling, producing progressively finer shafts. Counting hairs can miss that entirely, because the count barely changes while the scalp visibly shows through.
This is also why the two measurements can disagree about whether something worked. A treatment that reverses miniaturisation shows up first as calibre. A treatment that extends the growth phase shows up first as count. Products are usually marketed on whichever number moved. Thickening shampoos sidestep the question altogether by coating the shaft rather than changing what the follicle produces — a real optical effect that washes out, and one we take apart on peptide shampoo.
The oral collagen results, read carefully
The two 2026 trials are the newest substantial data in this whole area and deserve to be reported accurately rather than dismissed.
In J Med Food, 114 women aged 20 to 50 with thigh cellulite and self-reported hair thinning were randomised to a low-molecular-weight fish collagen peptide at 1,000 mg a day or placebo for 24 weeks. Cellulite severity, dermal-subcutaneous border length, skin roughness and elasticity all improved against placebo at weeks 12 and 24, and hair diameter increased significantly at week 24, with a larger proportion of the treated group showing measurable thickening. The paper also reports pharmacokinetics: the hydrolysate produced roughly 54-fold higher two-hour exposure to the tripeptide Gly-Pro-Hyp than general collagen, which is the mechanistic argument for why a specific hydrolysate might behave differently from collagen in general.
In Int J Stem Cells, Korean adults aged 19 to 60 with damaged hair but no alopecia took 3 g a day of a different collagen peptide for 24 weeks, with significant improvement in hair gloss measured by gloss meter and scanning electron microscopy. Gloss is a cuticle-surface property. It is a reasonable thing to measure in damaged hair and it is not thickness.
Both were authored by people at the companies producing the ingredients, and both enrolled populations without diagnosed hair loss — people with cellulite, people with damaged hair. That is a legitimate cosmetic population and it is not the population most readers of a thickening claim belong to. Our collagen peptides for hair and skin page carries the wider oral-collagen picture, and the sex composition of these studies is examined on peptides for hair growth in women.
What would settle it
The trial that does not exist is straightforward to describe: a topical peptide against placebo, in a population with diagnosed thinning of both sexes, running long enough to cover a full hair cycle, reporting mean shaft diameter as well as the proportion crossing a stated threshold, and run by people who do not sell the ingredient. Every element of that already exists somewhere in the literature above; none of the studies has all of them.
Until one does, the defensible summary is narrow. One topical peptide raised the proportion of thick hairs in 22 men. One oral collagen peptide raised hair diameter in 114 women whose trial was about cellulite. The rest of the thickness shelf is measured on counts, on gloss, on markers, or on nothing at all — and the wider evidence tiers for each ingredient are set out on peptides for hair growth.
Sources
- Iwabuchi T et al. The topical penta-peptide Gly-Pro-Ile-Gly-Ser increases the proportion of thick hair in Japanese men with androgenetic alopecia. J Cosmet Dermatol 2016;15(2):176-84.
- Hwang S et al. Low-Molecular-Weight Collagen Peptide Supplementation Improves Cellulite Severity, Skin Elasticity, and Hair Shaft Diameter. J Med Food 2026;29(4):187-195.
- Kim TK et al. Efficacy and Safety of Low-Molecular-Weight Collagen Peptide GT for Improving Hair Condition in Individuals with Damaged Hair. Int J Stem Cells 2026, online ahead of print.
- Dietary Collagen Supplementation as a Strategy for Skin Health. Nutrients 2026.
- PubMed counts run 2026-09-10 with the queries printed above.
